Neuroscience Meeting To Feature Feisty Debate On Alzheimer's Etiology

Alzheimer's Etiology Author: Robert Finn SIDEBAR: Sources of Information on Alzheimer's Research The annual meeting of the Society for Neuroscience has long featured "special interest socials"-low-key, early-evening events typically providing members of particular subfields with an opportunity to listen to brief presentations and network with their colleagues over sips of wine and nibbles of cheese. But at this year's meeting (to be held November 11-16 in San Diego), one of the 24 get-together

Written byRobert Finn
| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share

Alzheimer's Etiology Author: Robert Finn

SIDEBAR: Sources of Information on Alzheimer's Research

The annual meeting of the Society for Neuroscience has long featured "special interest socials"-low-key, early-evening events typically providing members of particular subfields with an opportunity to listen to brief presentations and network with their colleagues over sips of wine and nibbles of cheese. But at this year's meeting (to be held November 11-16 in San Diego), one of the 24 get-togethers promises to be just a bit more exciting. It will air opinions on the most polarizing controversy in Alzheimer's disease (AD) research in a public argument among four high-profile AD researchers.

CHAIRWOMAN: Alison Goate, herself a key amyloidologist, will lead next month's debate. This clash of the titans will be a semi-formal debate over the motion "This house believes b-amyloid deposition causes Alzheimer's disease," and it will take place on Tuesday, November 14, from 5:30 to 7:30 ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies